# Docetaxel in Treating Patients With Solid Tumors

> **NCT00003565** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 109 (actual)

## Conditions studied

- Bladder Cancer
- Breast Cancer
- Head and Neck Cancer
- Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00003565
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2006-01
- **Final completion:** 2008-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2016-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003565, "Docetaxel in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00003565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*